Phoenix/ Sports

Wickenburg Rallies Around 14-Year-Old Football Player Fighting Leukemia

AI Assisted Icon
Published on October 05, 2026
Wickenburg Rallies Around 14-Year-Old Football Player Fighting LeukemiaSource: Peter Flass / Wikimedia Commons

A 14-year-old football player from Wickenburg is undergoing chemotherapy for leukemia at Phoenix Children's Hospital, and his small Arizona hometown has responded by rallying around him. Tripp Davis remains part of the Wickenburg Wranglers program even as he fights the disease, with neighbors, classmates and fans showing their support in a community that has made his battle its own.

The outpouring was captured on camera by photojournalist Laura Hess for FOX 10 Phoenix, which reported that “the community of Wickenburg is rallying around Tripp Davis, a teen undergoing chemotherapy for leukemia at Phoenix Children's Hospital.” The station's report focused on how the town has shown up for the teenager during treatment, with Hess documenting the scenes of local support.

A Roster Spot That Means More Than Stats

Even while undergoing treatment, Davis has stayed connected to the team that gave the story its local roots. According to MaxPreps, Davis has been added to Wickenburg's 2026 football roster, and his statistics were entered following the Wranglers' 44-0 win over Greyhills Academy on Friday, Aug. 28, 2026. The same record lists him as ranked in the top six in two statistical categories within the 3A Independent classification.

Those numbers offer a small but tangible thread connecting Davis to the team on the field, even as his more pressing fight continues inside the hospital. The site's career profile does not detail which two stats he ranks among the leaders in, only that he holds a top-six position in the classification.

Childhood Leukemia's Broader Context

Broader data offers context on the disease without speaking to his individual case. The American Cancer Society notes that “about 3 in 4 leukemias among children and teens are acute lymphoblastic leukemia (ALL)” and that “most of the remaining cases are acute myeloid leukemia (AML),” though nothing confirms which type Davis has.

Medical researchers caution against drawing conclusions about any one patient from broad figures. The National Cancer Institute's SEER program states that “because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient,” adding that “no two patients are entirely alike, and treatment and responses to treatment can vary greatly.”

For now, the clearest picture to emerge is one of a small Arizona town standing behind one of its own. Tripp Davis continues chemotherapy in Phoenix while his Wickenburg community, and a roster spot waiting for him, keep his name part of the Wranglers' season.